Unlock instant, AI-driven research and patent intelligence for your innovation.

Amphiphilic medicine-medicine nanoparticle medicine for reversing multidrug resistance of tumor on platinum type anti-cancer medicine, and preparation method and application thereof

A multi-drug resistance and nanoparticle technology, which is applied in the field of anti-tumor drugs, can solve the problems of inflammation in kidneys and other organs and other diseases, and achieve high yield, reduce blockage, and reduce toxic and side effects

Active Publication Date: 2017-06-20
SHANGHAI JIAO TONG UNIV
View PDF1 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] The first purpose of the present invention is to provide an amphiphilic drug-drug nanoparticle drug for reversing the multidrug resistance of tumors to platinum anticancer drugs, so as to solve the problem of tumors in the prior art to platinum anticancer drugs. Multidrug resistance, and nanocarriers themselves need to be excreted through kidneys and other organs after drug delivery, which may cause inflammation in kidneys and other organs or cause some other diseases

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Amphiphilic medicine-medicine nanoparticle medicine for reversing multidrug resistance of tumor on platinum type anti-cancer medicine, and preparation method and application thereof
  • Amphiphilic medicine-medicine nanoparticle medicine for reversing multidrug resistance of tumor on platinum type anti-cancer medicine, and preparation method and application thereof
  • Amphiphilic medicine-medicine nanoparticle medicine for reversing multidrug resistance of tumor on platinum type anti-cancer medicine, and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] Embodiment 1: The preparation of an amphiphilic drug-drug nanoparticle drug for reversing the multidrug resistance of tumors to platinum anticancer drugs in this embodiment 1 specifically includes the following steps:

[0034] (1) Dissolve 300 mg of cisplatin and 169.87 mg of silver nitrate in 10 mL of DMF, react for 24 hours and remove the precipitated silver chloride to obtain the supernatant as solution 1; mix and disperse 88.1 mg of vorinostat and 13.3 mg of sodium hydroxide In 5 mL of methanol, the insoluble matter was removed after the reaction, and the supernatant was obtained as solution 2; after the solution 1 and solution 2 were mixed and reacted for 48 hours, the organic solvent was removed, the excess cisplatin was dissolved in methanol, and the amphiphilic drug was obtained by recrystallization. - drug complex, its structural formula (1) is as follows;

[0035]

[0036] Structural formula (a) 1H-NMR nuclear magnetic spectrum, mass spectrogram and infrar...

Embodiment 2

[0038] Embodiment 2: The preparation of an amphiphilic drug-drug nanoparticle drug for reversing the multidrug resistance of tumors to platinum anticancer drugs in this embodiment 2 specifically includes the following steps:

[0039] (1) Dissolve 391mg of picoplatin and 169.87mg of silver nitrate in 10mL of DMF, react for 24h to remove the silver chloride precipitate, and obtain the supernatant as solution 1; mix 100.7mg of trichostatin A with 35.3mg of sodium carbonate Disperse in 5mL of methanol, remove the insoluble matter after the reaction, and obtain the supernatant solution 2; after mixing the solution 1 and the solution 2 for 48 hours, remove the organic solvent, dissolve and remove the excess picoplatin with methanol, and recrystallize to obtain amphiphilic Drug-drug complex, its structural formula (2) is as follows;

[0040]

[0041] (2) Dissolve the amphiphilic drug-drug complex prepared above in methanol, drop it into water at room temperature, remove methanol, ...

Embodiment 3

[0042] Embodiment 3: The preparation of an amphiphilic drug-drug nanoparticle drug for reversing the multidrug resistance of tumors to platinum anticancer drugs in this embodiment 3 specifically includes the following steps:

[0043] (1) Dissolve 300mg cisplatin and 169.87mg silver nitrate in 10mL DMF, remove the silver chloride precipitate after reacting for 24h, and obtain the supernatant as solution one; mix 42.3mg 3,4-dihydroxybenzohydroxamic acid with Mix and disperse 35.3 mg of sodium carbonate in 5 mL of DMF, remove the insoluble matter after the reaction, and obtain the supernatant as solution 2; after mixing and reacting solution 1 and solution 2 for 48 hours, remove the organic solvent, dissolve and remove excess cisplatin with methanol, and recrystallize Obtain the amphiphilic drug-drug complex, and its structural formula (3) is as follows;

[0044]

[0045] (2) dissolving the amphiphilic drug-drug complex prepared above in dimethyl sulfoxide, dripping it into wa...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
sizeaaaaaaaaaa
Login to View More

Abstract

The invention discloses amphiphilic medicine-medicine nanoparticle medicine for reversing multidrug resistance of tumor on platinum type anti-cancer medicine. A histone histone deacetylase inhibitor and platinum type anti-cancer medicine are coordinated, and are assembled by self to form nanoparticles in water; after the nanoparticles enter tumor cells, the two kinds of medicine are released through hydrolysis. The amphiphilic coordination complex can be assembled by self to form the nanoparticles in the water; any medicine conveying carrier is not needed; the coordination complex self can realize medicine conveying and can effectively enter the tumor cells; the retardation effect of sulfur-containing ligands in blood on cis-platinum is lowered; the toxic and side effects on normal cells are reduced; the histone histone deacetylase inhibitor and the platinum type anti-cancer active medicine can be released through hydrolysis; the goals of the two kinds of medicine for cooperatively reversing the multidrug resistance of tumor on platinum type medicine and treating cancer are achieved.

Description

technical field [0001] The invention belongs to the technical field of antineoplastic drugs, and in particular relates to an amphiphilic drug-drug nanoparticle drug for reversing multidrug resistance of tumors to platinum anticancer drugs, a preparation method and application thereof. Background technique [0002] Malignant tumors (cancers) have been the main diseases that lead to an increase in mortality in countries all over the world. Therefore, how to effectively treat malignant tumors has become one of the problems to be solved urgently in the world. At present, the treatment methods for malignant tumors mainly include the following types: surgical resection, chemotherapy, radiation and ablation therapy, immune and biological therapy. Among many methods, chemotherapy is one of the most convenient and widely used effective treatment methods, and the most widely used type is platinum anticancer drugs. [0003] However, most platinum-based antineoplastic drugs have the f...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K47/55A61K9/14A61K45/06A61K33/24A61K31/555A61P35/00A61K31/167A61K31/165A61K31/185A61K31/19
CPCA61K9/14A61K31/165A61K31/167A61K31/185A61K31/19A61K31/555A61K33/24A61K45/06A61K2300/00A61K9/5123A61K31/282A61P35/00
Inventor 徐舒婷颜德岳黄卫朱新远周永丰
Owner SHANGHAI JIAO TONG UNIV